BioCryst Adds $350 Million in New Financing with Royalty Pharma and OMERS Capital Markets
November 22, 2021 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
—Provides funding for BCX9930/oral Factor D program across multiple indications— —Agreements supported by strength of ORLADEYO® (berotralstat) launch and confidence in future opportunity— NEW YORK,...
Mocana TrustCenter Delivers On-Device Protection for OT, IoT and IIoT RTOS and Enterprise Platforms
July 21, 2021 10:52 ET
|
Mocana
SAN JOSE, Calif., July 21, 2021 (GLOBE NEWSWIRE) -- Mocana has released the latest version of its TrustCenter cybersecurity protection platform for embedded real-time operating systems (RTOS) and...
Proactive news headlines including VR Resources, Dalrada Corp, Cloud DX and Kenorland Minerals
July 14, 2021 14:19 ET
|
Proactive Investors
New York , July 14, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies TNR...
LexaGene Retains Wolf Greenfield Intellectual Property Law Firm
July 14, 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops a fully automated rapid pathogen...
GT Gold Reports Results From Quash Pass Drilling
February 16, 2021 07:30 ET
|
GT Gold Corp
VANCOUVER, British Columbia, Feb. 16, 2021 (GLOBE NEWSWIRE) -- GT Gold Corp. (TSX-V:GTT; OTCQX:GTGDF) (the “Company” or “GT Gold”) today announces the results of a drilling program at Quash Pass, on...
Kymera Therapeutics Strengthens Leadership with Key Appointments and Promotions
February 03, 2021 07:00 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule...
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
December 07, 2020 08:45 ET
|
RP Management, LLC
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Athyrium Capital Management, LP today...
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
December 07, 2020 08:40 ET
|
BioCryst Pharmaceuticals, Inc.
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq: RPRX) and Athyrium Capital Management, LP...
Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents
October 15, 2020 07:00 ET
|
Precision Biosciences
DURHAM, N.C., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies...
High Real Estate Group Welcomes Armstrong Flooring Inc. Headquarters to Greenfield
June 29, 2020 14:00 ET
|
High Companies
LANCASTER, Pa., June 29, 2020 (GLOBE NEWSWIRE) -- Armstrong Flooring, Inc. (NYSE: AFI) will relocate its corporate headquarters to Greenfield in 2021. The 160-year-old global leader in the design...